FDCC
SWAV

Foster Dykema Cabot & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Foster Dykema Cabot & Co’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28
Closed -$8K – 408
2023
Q2 		$8K Buy
+28
New +$7.78K ﹤0.01% 270

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Foster Dykema Cabot & Co's SWAV Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 28 shares — an estimated $8K sold.

Foster Dykema Cabot & Co first reported a position in SWAV in Q2 2023 and held it in 1 quarter. The position peaked at $8K in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Foster Dykema Cabot & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Foster Dykema Cabot & Co sold 28 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $8K.
  • Foster Dykema Cabot & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Foster Dykema Cabot & Co's Shockwave Medical, Inc. Common Stock position peaked at $8K in Q2 2023.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.